Browsing: eli lilly

Novo Nordisk hits 0bn market value, climbing closer to the tn club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year

Novo Nordisk hits $500bn market value, climbing closer to the $1tn club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year

By Press Room31 January 2024

Novo Nordisk has shown few signs of slowing down since taking the pharmaceutical world by storm last year. Now, the…

North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit 0B by 2030

North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030

By Press Room27 January 2024

North Carolina is cutting off coverage of anti-obesity medications for state employees, citing soaring costs and a lack of agreement…

Alphabet’s Isomorphic labs to collaborate with Novartis, Lilly on AI-driven drug discovery

Alphabet’s Isomorphic labs to collaborate with Novartis, Lilly on AI-driven drug discovery

By Press Room8 January 2024

Bloomberg—Isomorphic Labs, a subsidiary of Alphabet Inc., said it entered into strategic research collaboration agreements with Novartis AG and Eli…

Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of diabetes and obesity

Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of diabetes and obesity

By Press Room5 January 2024

Eli Lilly and Co. on Thursday warned against use of its popular diabetes and weight loss drugs Mounjaro and Zepbound…